Showing results (1-10 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|June 15, 2021
Efavirenz Loaded Mixed Polymeric Micelles: Formulation, Optimization, and In Vitro CharacterizationJyotsana R Madan, Shrikant G Dere, Rajendra Awasthi, et al.
Assay and Drug Development Technologies|December 6, 2022
Development and Validation of Reverse-Phase High-Performance Liquid Chromatography Based Bioanalytical Method for Estimation of Simvastatin in Rat's PlasmaHardeep, Narendra Kumar Pandey, Sachin Kumar Singh, et al.
Assay and Drug Development Technologies|February 12, 2011
Functional characterization and high-throughput screening of positive allosteric modulators of α7 nicotinic acetylcholine receptors in IMR-32 neuroblastoma cellsSujatha M Gopalakrishnan, Betsy M Philip, Jens Halvard Gronlien, et al.
Assay and Drug Development Technologies|February 12, 2011
The zebrafish: a powerful platform for in vivo, HTS drug discoveryChris Delvecchio, Jens Tiefenbach, Henry M Krause
Assay and Drug Development Technologies|November 6, 2010
Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinaseSergey A Shiryaev, Anton V Cheltsov, Katarzyna Gawlik, et al.
Assay and Drug Development Technologies|November 6, 2010
A high-throughput screening strategy to overcome virus instabilityLynn Rasmussen, Clinton Maddox, Blake P Moore, et al.
Assay and Drug Development Technologies|November 6, 2010
Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterolJun Zhang, Sutang Cai, Blake R Peterson, et al.
Assay and Drug Development Technologies|December 25, 2010
Validation of a high-content screening assay using whole-well imaging of transformed phenotypesChristina N Ramirez, Tatsuya Ozawa, Toshimitsu Takagi, et al.
Assay and Drug Development Technologies|February 2, 2011
A screen to identify small molecule inhibitors of protein-protein interactions in mycobacteriaDeborah Mai, Jennifer Jones, John W Rodgers, et al.
Assay and Drug Development Technologies|July 29, 2010
Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2Drew D Dudgeon, Sunita N Shinde, Tong Ying Shun, et al.
Pageof 100